ANIK logo

Anika Therapeutics (ANIK) Accounts Payable

Annual Accounts Payable

$9.86 M
+$786.00 K+8.66%

December 31, 2023


Summary


Performance

ANIK Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANIKbalance sheetmetrics:

Quarterly Accounts Payable

$6.80 M
-$3.19 M-31.91%

September 30, 2024


Summary


Performance

ANIK Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANIKbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

ANIK Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+8.7%-17.5%
3 y3 years+9.8%-14.3%
5 y5 years+213.7%+151.8%

ANIK Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+29.2%-32.1%at low
5 y5-yearat high+157.3%-32.1%+77.6%
alltimeall timeat high+2725.2%-32.1%+2168.3%

Anika Therapeutics Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$6.80 M(-31.9%)
Jun 2024
-
$9.99 M(-0.3%)
Mar 2024
-
$10.02 M(+1.6%)
Dec 2023
$9.86 M(+8.7%)
$9.86 M(+19.5%)
Sep 2023
-
$8.25 M(+3.9%)
Jun 2023
-
$7.94 M(-11.2%)
Mar 2023
-
$8.95 M(-1.4%)
Dec 2022
$9.07 M(+18.9%)
$9.07 M(+8.6%)
Sep 2022
-
$8.35 M(+2.3%)
Jun 2022
-
$8.16 M(+9.7%)
Mar 2022
-
$7.44 M(-2.5%)
Dec 2021
$7.63 M(-15.0%)
$7.63 M(-3.9%)
Sep 2021
-
$7.94 M(-2.0%)
Jun 2021
-
$8.10 M(-6.7%)
Mar 2021
-
$8.68 M(-3.4%)
Dec 2020
$8.98 M(+134.4%)
$8.98 M(+32.1%)
Sep 2020
-
$6.80 M(+10.4%)
Jun 2020
-
$6.16 M(-37.8%)
Mar 2020
-
$9.91 M(+158.5%)
Dec 2019
$3.83 M(+21.9%)
$3.83 M(+41.8%)
Sep 2019
-
$2.70 M(+18.1%)
Jun 2019
-
$2.29 M(-36.0%)
Mar 2019
-
$3.57 M(+13.6%)
Dec 2018
$3.14 M(-53.4%)
$3.14 M(+27.7%)
Sep 2018
-
$2.46 M(-51.5%)
Jun 2018
-
$5.07 M(-17.6%)
Mar 2018
-
$6.16 M(-8.7%)
Dec 2017
$6.75 M(+193.0%)
$6.75 M(+30.0%)
Sep 2017
-
$5.19 M(-5.1%)
Jun 2017
-
$5.46 M(-9.7%)
Mar 2017
-
$6.05 M(+162.7%)
Dec 2016
$2.30 M(-72.3%)
$2.30 M(+18.2%)
Sep 2016
-
$1.95 M(-40.8%)
Jun 2016
-
$3.29 M(+1.0%)
Mar 2016
-
$3.26 M(-60.7%)
Dec 2015
$8.30 M(+591.3%)
$8.30 M(+273.8%)
Sep 2015
-
$2.22 M(+34.0%)
Jun 2015
-
$1.66 M(-6.6%)
Mar 2015
-
$1.77 M(+47.8%)
Dec 2014
$1.20 M(-57.0%)
$1.20 M(+2.9%)
Sep 2014
-
$1.17 M(-46.9%)
Jun 2014
-
$2.20 M(-19.9%)
Mar 2014
-
$2.74 M(-1.8%)
Dec 2013
$2.79 M(+19.3%)
$2.79 M(+30.8%)
Sep 2013
-
$2.14 M(-20.9%)
Jun 2013
-
$2.70 M(+0.1%)
Mar 2013
-
$2.70 M(+15.1%)
Dec 2012
$2.34 M(-45.5%)
$2.34 M(+22.8%)
Sep 2012
-
$1.91 M(-51.6%)
Jun 2012
-
$3.94 M(+1.6%)
Mar 2012
-
$3.88 M(-9.7%)
Dec 2011
$4.30 M(-55.6%)
$4.30 M(+12.1%)
Sep 2011
-
$3.84 M(-49.4%)
Jun 2011
-
$7.59 M(-17.2%)
Mar 2011
-
$9.16 M(-5.5%)
Dec 2010
$9.69 M(+52.6%)
$9.69 M(+5.8%)
Sep 2010
-
$9.16 M(+23.6%)
Jun 2010
-
$7.41 M(+5.7%)
Mar 2010
-
$7.01 M(+10.4%)
Dec 2009
$6.35 M(+167.5%)
$6.35 M(+420.6%)
Sep 2009
-
$1.22 M(-31.0%)
Jun 2009
-
$1.77 M(-13.1%)
Mar 2009
-
$2.04 M(-14.3%)
Dec 2008
$2.38 M
$2.38 M(-13.2%)
DateAnnualQuarterly
Sep 2008
-
$2.74 M(-13.0%)
Jun 2008
-
$3.15 M(+101.2%)
Mar 2008
-
$1.56 M(-67.9%)
Dec 2007
$4.87 M(+404.2%)
$4.87 M(+16.3%)
Sep 2007
-
$4.18 M(+60.0%)
Jun 2007
-
$2.62 M(+139.7%)
Mar 2007
-
$1.09 M(+13.1%)
Dec 2006
$965.20 K(-24.5%)
$965.20 K(+22.9%)
Sep 2006
-
$785.20 K(-24.7%)
Jun 2006
-
$1.04 M(+32.0%)
Mar 2006
-
$789.30 K(-38.2%)
Dec 2005
$1.28 M(+61.5%)
$1.28 M(-22.8%)
Sep 2005
-
$1.66 M(+334.6%)
Jun 2005
-
$381.00 K(-51.5%)
Mar 2005
-
$786.00 K(-0.6%)
Dec 2004
$791.00 K(+126.6%)
$791.00 K(-5.4%)
Sep 2004
-
$836.00 K(+42.4%)
Jun 2004
-
$587.00 K(-27.1%)
Mar 2004
-
$805.00 K(+130.7%)
Dec 2003
$349.00 K(-58.7%)
$349.00 K(-18.5%)
Sep 2003
-
$428.00 K(+5.4%)
Jun 2003
-
$406.00 K(-43.5%)
Mar 2003
-
$719.00 K(-14.9%)
Dec 2002
$845.00 K(-11.5%)
$845.00 K(+8.7%)
Sep 2002
-
$777.10 K(+1.5%)
Jun 2002
-
$765.90 K(+9.0%)
Mar 2002
-
$702.80 K(-26.4%)
Dec 2001
$954.60 K(+9.7%)
$954.60 K(+8.3%)
Sep 2001
-
$881.10 K(-46.7%)
Jun 2001
-
$1.65 M(+113.4%)
Mar 2001
-
$773.80 K(-11.1%)
Dec 2000
$870.50 K(+45.1%)
$870.50 K(+82.0%)
Sep 2000
-
$478.20 K(-63.5%)
Jun 2000
-
$1.31 M(+210.7%)
Mar 2000
-
$421.40 K(-29.8%)
Dec 1999
$600.00 K(-33.3%)
$600.00 K(-14.3%)
Sep 1999
-
$700.00 K(-12.5%)
Jun 1999
-
$800.00 K(-38.5%)
Mar 1999
-
$1.30 M(+44.4%)
Dec 1998
$900.00 K(-10.0%)
$900.00 K(+28.6%)
Sep 1998
-
$700.00 K(-22.2%)
Jun 1998
-
$900.00 K(+28.6%)
Mar 1998
-
$700.00 K(-30.0%)
Dec 1997
$1.00 M(+66.7%)
$1.00 M(+25.0%)
Sep 1997
-
$800.00 K(+60.0%)
Jun 1997
-
$500.00 K(-28.6%)
Mar 1997
-
$700.00 K(+16.7%)
Dec 1996
$600.00 K(0.0%)
-
Nov 1996
-
$600.00 K(0.0%)
Aug 1996
-
$600.00 K(+50.0%)
Aug 1996
$600.00 K(+50.0%)
-
May 1996
-
$400.00 K(-33.3%)
Feb 1996
-
$600.00 K(+20.0%)
Nov 1995
-
$500.00 K(+25.0%)
Aug 1995
$400.00 K(-20.0%)
$400.00 K(-20.0%)
May 1995
-
$500.00 K(+66.7%)
Feb 1995
-
$300.00 K(-25.0%)
Nov 1994
-
$400.00 K(-20.0%)
Aug 1994
$500.00 K(-50.0%)
$500.00 K(0.0%)
May 1994
-
$500.00 K(+66.7%)
Feb 1994
-
$300.00 K(-62.5%)
Nov 1993
-
$800.00 K(-20.0%)
Aug 1993
$1.00 M
$1.00 M(+233.3%)
May 1993
-
$300.00 K

FAQ

  • What is Anika Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Anika Therapeutics?
  • What is Anika Therapeutics annual accounts payable year-on-year change?
  • What is Anika Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Anika Therapeutics?
  • What is Anika Therapeutics quarterly accounts payable year-on-year change?

What is Anika Therapeutics annual accounts payable?

The current annual accounts payable of ANIK is $9.86 M

What is the all time high annual accounts payable for Anika Therapeutics?

Anika Therapeutics all-time high annual accounts payable is $9.86 M

What is Anika Therapeutics annual accounts payable year-on-year change?

Over the past year, ANIK annual accounts payable has changed by +$786.00 K (+8.66%)

What is Anika Therapeutics quarterly accounts payable?

The current quarterly accounts payable of ANIK is $6.80 M

What is the all time high quarterly accounts payable for Anika Therapeutics?

Anika Therapeutics all-time high quarterly accounts payable is $10.02 M

What is Anika Therapeutics quarterly accounts payable year-on-year change?

Over the past year, ANIK quarterly accounts payable has changed by -$1.45 M (-17.53%)